The tissue diagnostics market is expected to gain strong growth opportunities during the forecast period. This growth is due to the increasing prevalence of cancer. COVID-19 has impacted the tissue diagnostics industry primarily. Diagnostic testing was significantly slowed down during the pandemic as there was a focus on containing the virus within medical resources. Routine medical processes are affected during the period. During the epidemic, the need for tissue diagnostics services and products went low temporarily. However, when things started becoming better and healthcare systems began adjusting to the new norm, the market again started to bounce up.
Global Tissue Diagnostics Market size was valued at USD 5.4 billion in 2023 and is poised to grow from USD 5.86 billion in 2024 to USD 11.35 billion by 2032, growing at a CAGR of 8.6% during the forecast period (2025-2032).
The post-pandemic world was characterized by a continued high requirement for a precise diagnosis and monitoring of several diseases, among which cancer was included. Considering the rapid increase in cancer incidence, anatomic pathology is changing fast. That again promotes the continuous expansion of the clinical pathology domain. The anatomical and molecular pathology domain are converging constantly.
Get a Free Sample PDF of the Report – https://www.skyquestt.com/sample-request/tissue-diagnostics-market
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2032, Y-o-Y growth rate, and CAGR):
The Tissue Diagnostics Market can be segmented based on several factors, including product type, application, end-user, and distribution channel.
Global Tissue Diagnostics Market is segmented by Product Type, Technology, Disease Type, Modality, End-user and region.
Based on Product Type, the market is segmented into Consumables and Instruments.
Based on Technology, the market is segmented into Immunohistochemistry, In Situ Hybridization, Primary & Special Staining, Anatomic Pathology, Molecular Pathology, Digital Pathology & Workflow Management and Special Staining.
Based on Disease Type, the market is segmented into Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-small Cell Lung Cancer and Others.
Based on Modality, the market is segmented into Clinical and Pharma / CRO / Research Market.
Based on End-user, the market is segmented into Hospitals, Research Laboratories, Pharmaceutical Companies, Contract Research Organizations (CROs) and Others.
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Tissue Diagnostics Market – Regional Analysis:
The Tissue Diagnostics Market share of North America is major due to the high incidence rate of cancer. Some public efforts are being made towards reducing cancer cases and consequently increasing demand for cancer diagnostics in the local market. The main cancer prevention and control research network by the Centers for Disease Control and Prevention is on cancer prevention in this region.
Next, human tissue is an important area for new test development for personalized medicine. Personalized medicine has been greatly expanded by the increased utilization of the sequencing technologies and healthcare IT systems in clinical workflow, which have turned out to increase the utilization of tissue diagnostics.
However, Asia-Pacific is predicted to grow at a profitable pace over the projection period with increased accessibility to diverse tissue diagnostic tests by multinational firms. The collaborations targeted to boost the region’s capacity for diagnostics help sustain this growth. For instance, Hamamatsu Photonics K.K. and Indica Labs announced their agreement to cooperate in perfecting integrated digital pathology processes, with a view to improving access to advanced diagnostic technologies among healthcare professionals.
Top Market Players in Tissue Diagnostics Market are:
F. Hoffmann-La Roche Ltd. (Switzerland)
Abbott Laboratories (USA)
Thermo Fisher Scientific Inc. (USA)
Siemens Healthineers (Germany)
Danaher Corporation (USA)
bioMerieux SA (France)
QIAGEN N.V. (Netherlands)
Becton, Dickinson and Company (BD) (USA)
Merck KGaA (Germany)
GE Healthcare (USA)
BioGenex Laboratories (USA)
Cell Signaling Technology, Inc. (USA)
Bio SB (USA)
DiaGenic ASA (Norway)
Agilent Technologies (USA)
Fujirebio Inc. (Japan)
Tecan Group Ltd. (Switzerland)
STRATEC SE (Germany)
Seegene Inc. (South Korea)
Leica Biosystems (Germany)
Tissue Diagnostics Market Recent Developments:
In May 2021, Discovery Life Sciences, a global biospecimen, and biomarker-specialists company has announced to acquire Targos Molecular Pathology GmbH, A Germany based molecular pathology laboratory. This acquisition is mainly aimed towards expansion of Discovery Life Science services, making it a global provider for biomarker development, and clinical trial support.
In May 2021, Roche Diagnostics, a sub-division of the Hoffmann-La Roche Ltd. Announced its partnership with Canadian Blood Services, a Canadian based non-profit organization to expand the study immune response to SARS-CoV-2.
You may Also Like
https://medium.com/@kathan.trivedi/%EC%97%90%EB%84%88%EC%A7%80-%EC%9D%8C%EB%A3%8C-%EC%8B%9C%EC%9E%A5-%EB%8F%99%ED%96%A5-%EC%84%B1%EC%9E%A5-%EA%B8%B0%ED%9A%8C-%EB%B0%8F-%EB%AF%B8%EB%9E%98-%EC%A0%84%EB%A7%9D-7b2e622a5c3b
https://medium.com/@kathan.trivedi/water-and-wastewater-treatment-market-trends-growth-opportunities-and-future-outlook-6f96f1c42b62
Forward-Looking Insights
The Tissue Diagnostics Market is set to experience sustained growth, fueled by technological advancements, broader global market access, and rising industry demand. With the industry addressing emerging challenges and capitalizing on new opportunities, it is expected to drive innovation and play a pivotal role in advancing global health and economic progress.
About Company:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact Details:
SkyQuest Technology Group
USA (+1) 351-333-4748
Email: [email protected]”
